what qualifies you for glp-1 to say when requesting options: guide to getting your prescription The GLP-1 Agonists and Obesity:
Description
However, many patients tolerate the medication well when dosing is careful and progressive
AE were mainly nausea and vomiting which were transient
doi: 10.1016/j.ejphar.2008.03.025 172 GenglerSMcCleanPLMcCurtinRGaultVAHolscherC
RosenstockJHansenLZeePLiYCookWHirshbergBet al
Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats
Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene
